Page results
-
The High Court has today (26 March) ruled that parents can consent on behalf of their child for hormone-blocking treatment in cases of gender dysphoria.
-
UCLH has recruited the first European participant to a trial looking at treating non-hospitalised Covid-19 patients with the drug remdesivir.
-
This page provides information about the WEB device and how it is used to treat cerebral (brain) aneurysms
-
Our outpatient clinics will remain predominantly virtual throughout the COVID-19 pandemic. Please continue to refer via the NHS e-referral service.
-
All GPs are now welcome to use our national Infectious & Tropical Disease Advice and Guidance function on the e-referral system (NHS e-RS)
-
T16 North is a specialist adult haematology inpatient ward dedicated to providing high-quality care for patients with a wide range of blood disorders.
-
Around 1 in 250 women may experience consciousness during pregnancy-related surgery under general anaesthesia, according to a national study which sheds light on why this occurs.
-
The spasticity team at The National Hospital for Neurology and Neurosurgery (NHNN) has produced a series of short animated videos. The films were funded by The National Brain Appeal, the charity dedicated to supporting NHNN.
-
The aim of this page is to provide you with information about flow-diverting stents and how they are used to treat cerebral (brain) aneurysms.
-
Every five years, a national Peer Review process casts a supportive but critical eye over red cell services across the UK.
File results
-
FOI/2022/0652 - UCLH palliative care policy
-
FOI/2022/0656 - Reinforced autoclaved aerated concrete (RAAC)
-
FOI/2022/0660 - Prostate cancer
-
FOI/2022/0663 - Migraine treatment
-
FOI/2022/0665 - Formal patient/ family complaints
-
FOI/2022/0677 - Documents relating to the lift being out of order (RLHIM Lift 2 by reception)
-
FOI/2022/0681 - Deep brain stimulation procedure
-
FOI/2022/0679 - Theatre management, AA's and ODPs
-
FOI/2022/0646 - Endoscopic Retrogade Cholangiopancreatography
-
FOI/2022/0675 - Drug treatment for Paediatric patients (ages 0-16)